{"id":"NCT00337103","sponsor":"Eisai Inc.","briefTitle":"E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes","officialTitle":"A Phase III Open Label, Randomized Two-Parallel-Arm Multicenter Study of E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-09-20","primaryCompletion":"2012-03-12","completion":"2017-12-11","firstPosted":"2006-06-15","resultsPosted":"2013-09-30","lastUpdate":"2020-06-18"},"enrollment":1276,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Metastatic Breast Cancer"],"interventions":[{"type":"DRUG","name":"Eribulin Mesylate","otherNames":[]},{"type":"DRUG","name":"Capecitabine","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare E7389 versus capecitabine in patients with locally advanced or metastatic breast cancer who are refractory to the most recent chemotherapy. This is an open-label, randomized, two-parallel arm study. Patients will be randomized to receive either E7389 or capecitabine on a one-to-one ratio.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From date of randomization until date of death from any cause, assessed up to data cutoff date of 12 Mar 2012, or up to approximately 6 years","effectByArm":[{"arm":"Eribulin Mesylate 1.4 mg/m^2","deltaMin":484,"sd":null},{"arm":"Capecitabine 2.5 g/m^2/Day","deltaMin":440,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":169,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","Czechia","France","Germany","Greece","Hungary","Israel","Italy","Mexico","Poland","Romania","Russia","Singapore","South Africa","Spain","Taiwan","Ukraine"]},"refs":{"pmids":["27398025","27391598","26567010","25605862","20299316"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":95,"n":544},"commonTop":["Neutropenia","Nausea","Palmar-Plantar Erythrodysaesthesia Syndrome","Diarrhoea","Leukopenia"]}}